One synthesis.
Three vantage points.
The exam room, the research question, and the population each need to see the same patient clearly — from a different distance.
See the whole patient, before they sit down.
Every visit starts with the full trajectory already assembled — labs in context, adherence, body composition and the signals in between. And between visits, Longova flags the patients quietly drifting off therapy, while there is still time to reach them.
- The whole trajectory ready at the start of every visit
- Early warning when a patient starts to disengage
- Less time reconstructing history, more time on care
Real-world evidence, grounded in continuous data.
How do patients actually do on therapy once the trial ends? Longova answers with continuous, real-world signal rather than recall or claims — persistence, tolerability, and the outcomes that determine whether a therapy delivers its promise in practice.
- Persistence and tolerability as they happen in the real world
- The reasons behind discontinuation, not just the fact of it
- Evidence generated to publishable, comparable standards
Value that holds up to scrutiny.
A therapy only delivers value if patients stay on it and benefit. Longova measures the retention and outcomes that decide that question, and frames them the way a budget holder needs — including the cost per patient actually retained on therapy.
- Retention and outcomes measured, not assumed
- Cost per additional patient retained on therapy
- Budget-impact views for real adoption decisions
Different distances.
The same clear patient.
What makes Longova one product rather than three is that all three views are built on the same synthesized foundation — so the population your payers measure is the same patient your clinicians see.
Find your vantage point.
Tell us where you sit, and we'll shape the walkthrough around it.
Request a walkthrough